TGFB1 and cancer: It is worth noting that the enrichment of myogenic pathways in the high-risk samples may be due to the abnormal activation of cancer-associated fibroblasts, which promote stromal sclerosis and an immunosuppressive TME by secreting factors such as TGF-β.